Hypertension. 2005;45:710-716
Published online before print February 7, 2005,
doi: 10.1161/01.HYP.0000154681.38944.9a
(Hypertension. 2005;45:710.)
© 2005 American Heart Association, Inc.
Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability
Akira Nishiyama;
Li Yao;
Yuyan Fan;
Moe Kyaw;
Noriyuki Kataoka;
Ken Hashimoto;
Yukiko Nagai;
Emi Nakamura;
Masanori Yoshizumi;
Takatomi Shokoji;
Shoji Kimura;
Hideyasu Kiyomoto;
Katsuhiko Tsujioka;
Masakazu Kohno;
Toshiaki Tamaki;
Fumihiko Kajiya;
Youichi Abe
From the Department of Pharmacology (A.N., L.Y., Y.F., T.S., S.K., Y.A.), Research Equipment Center (Y.N.), and Second Department of Internal Medicine (H.K., M. Kohno), Kagawa Medical University, Japan; Department of Pharmacology (M. Kyaw, M.Y., T.T.), The University of Tokushima School of Medicine, Japan; Departments of Medical Engineering (N.K., F.K.) and Physiology (K.H., E.N., K.T.), Kawasaki Medical School, Kurashiki, Japan; and Department of Cardiovascular Physiology and Medical Engineering (F.K.), Okayama University Graduate School of Medicine and Dentistry, Japan.
Correspondence to Akira Nishiyama, MD, PhD, Department of Pharmacology, Kagawa Medical University 1750-1 Ikenobe, Miki-cho, Kita-gun Kagawa 761-0793, Japan. E-mail akira{at}kms.ac.jp
We demonstrated recently that chronic administration of aldosterone to rats induces glomerular mesangial injury and activates mitogen-activated protein kinases including extracellular signal-regulated kinases 1/2 (ERK1/2). We also observed that the aldosterone-induced mesangial injury and ERK1/2 activation were prevented by treatment with a selective mineralocorticoid receptor (MR) antagonist, eplerenone, suggesting that the glomerular mesangium is a potential target for injuries induced by aldosterone via activation of MR. In the present study, we investigated whether MR is expressed in cultured rat mesangial cells (RMCs) and involved in aldosterone-induced RMC injury. MR expression and localization were evaluated by Western blotting analysis and fluorolabeling methods. Cell proliferation and micromechanical properties were determined by [3H]-thymidine uptake measurements and a nanoindentation technique using an atomic force microscope cantilever, respectively. ERK1/2 activity was measured by Western blotting analysis with an anti-phospho–ERK1/2 antibody. Protein expression and immunostaining revealed that MR was abundant in the cytoplasm of RMCs. Aldosterone (1 to 100 nmol/L) dose-dependently activated ERK1/2 in RMCs with a peak at 10 minutes. Pretreatment with eplerenone (10 µmol/L) significantly attenuated aldosterone-induced ERK1/2 phosphorylation. Aldosterone (100 nmol/L) treatment for 30 hours increased [3H]-thymidine incorporation and decreased the elastic modulus, indicating cellular proliferative and deforming effects of aldosterone, respectively. These aldosterone-induced changes in cellular characteristics were prevented by pretreatment with eplerenone or an ERK (MEK) inhibitor, PD988059 (100 µmol/L). The results indicate that aldosterone directly induces RMC proliferation and deformability through MR and ERK1/2 activation, which may contribute to the pathogenesis of glomerular mesangial injury.
Key Words: mineralocorticoids • aldosterone
This article has been cited by other articles:
|
|
|
|
 
J. Du, Y.-Y. Fan, H. Hitomi, H. Kiyomoto, S. Kimura, C.-Z. Kong, T. Noma, M. Kohno, A. Nishiyama, and D. Nakano
Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats
Am J Physiol Renal Physiol,
September 1, 2009;
297(3):
F802 - F808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Becker, T. D. Hewitson, and A. Chrysostomou
Aldosterone in clinical nephrology--old hormone, new questions
Nephrol. Dial. Transplant.,
August 1, 2009;
24(8):
2316 - 2321.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Huang, A. Zhang, G. Ding, and R. Chen
Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation
Am J Physiol Renal Physiol,
June 1, 2009;
296(6):
F1323 - F1333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cortinovis, N. Perico, D. Cattaneo, and G. Remuzzi
Aldosterone and progression of kidney disease
Therapeutic Advances in Cardiovascular Disease,
April 1, 2009;
3(2):
133 - 143.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. M. Siragy and C. Xue
Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats
Exp Physiol,
July 1, 2008;
93(7):
817 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Huang, C. Xu, K. W. Kahng, N. A. Noble, W. A. Border, and Y. Huang
Aldosterone and TGF-{beta}1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells
Am J Physiol Renal Physiol,
June 1, 2008;
294(6):
F1287 - F1295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Irita, T. Okura, M. Kurata, K.-i. Miyoshi, T. Fukuoka, and J. Higaki
Osteopontin in Rat Renal Fibroblasts: Functional Properties and Transcriptional Regulation by Aldosterone
Hypertension,
February 1, 2008;
51(2):
507 - 513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gauer, V. Segitz, and M. Goppelt-Struebe
Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor
Nephrol. Dial. Transplant.,
November 1, 2007;
22(11):
3154 - 3159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zhang, Z. Jia, X. Guo, and T. Yang
Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin
Am J Physiol Renal Physiol,
September 1, 2007;
293(3):
F723 - F731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation
Am J Physiol Renal Physiol,
May 1, 2007;
292(5):
F1513 - F1525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Good
Nongenomic Actions of Aldosterone on the Renal Tubule
Hypertension,
April 1, 2007;
49(4):
728 - 739.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagase, S. Yoshida, S. Shibata, T. Nagase, T. Gotoda, K. Ando, and T. Fujita
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome: Possible Contribution of Fat-Derived Factors
J. Am. Soc. Nephrol.,
December 1, 2006;
17(12):
3438 - 3446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Guo, D. Martinez-Vasquez, G. P. Mendez, M. F. Toniolo, T. M. Yao, E. M. Oestreicher, T. Kikuchi, N. Lapointe, L. Pojoga, G. H. Williams, et al.
Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus
Endocrinology,
November 1, 2006;
147(11):
5363 - 5373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-P. Sun, M. Kohno, P. Guo, Y. Nagai, K. Miyata, Y.-Y. Fan, S. Kimura, H. Kiyomoto, K. Ohmori, D.-T. Li, et al.
Involvements of Rho-Kinase and TGF-beta Pathways in Aldosterone-Induced Renal Injury
J. Am. Soc. Nephrol.,
August 1, 2006;
17(8):
2193 - 2201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagase, S. Shibata, S. Yoshida, T. Nagase, T. Gotoda, and T. Fujita
Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker
Hypertension,
June 1, 2006;
47(6):
1084 - 1093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Miyata, M. Rahman, T. Shokoji, Y. Nagai, G.-X. Zhang, G.-P. Sun, S. Kimura, T. Yukimura, H. Kiyomoto, M. Kohno, et al.
Aldosterone Stimulates Reactive Oxygen Species Production through Activation of NADPH Oxidase in Rat Mesangial Cells
J. Am. Soc. Nephrol.,
October 1, 2005;
16(10):
2906 - 2912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagai, K. Miyata, G.-P. Sun, M. Rahman, S. Kimura, A. Miyatake, H. Kiyomoto, M. Kohno, Y. Abe, M. Yoshizumi, et al.
Aldosterone Stimulates Collagen Gene Expression and Synthesis Via Activation of ERK1/2 in Rat Renal Fibroblasts
Hypertension,
October 1, 2005;
46(4):
1039 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ishizawa, Y. Izawa, H. Ito, C. Miki, K. Miyata, Y. Fujita, Y. Kanematsu, K. Tsuchiya, T. Tamaki, A. Nishiyama, et al.
Aldosterone Stimulates Vascular Smooth Muscle Cell Proliferation Via Big Mitogen-Activated Protein Kinase 1 Activation
Hypertension,
October 1, 2005;
46(4):
1046 - 1052.
[Abstract]
[Full Text]
[PDF]
|
|
|
